Free Trial

Oxford Nanopore Technologies plc (ONT.L) - What Are Brokerages Thinking About This Stock?

Oxford Nanopore Technologies logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Broker sentiment is moderately bullish: Five of six analysts rate Oxford Nanopore Technologies a buy, while one recommends holding. The average 12-month price target is GBX 198.60.
  • Insiders have been buying shares: Executives purchased 39,885 shares over the past 90 days, worth approximately £7.76 million, bringing insider ownership to 2.53%.
  • The stock is trading near its recent highs but remains loss-making: Shares opened at GBX 211.80, compared with a 12-month range of GBX 95.61 to GBX 238.80. The company reported a quarterly loss of GBX 4.90 per share and negative profitability metrics.
  • Five stocks to consider instead of Oxford Nanopore Technologies.

Oxford Nanopore Technologies plc (LON:ONT - Get Free Report) has received an average rating of "Moderate Buy" from the six brokerages that are currently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is GBX 198.60.

Several research firms recently commented on ONT. Peel Hunt reissued a "hold" rating and set a GBX 153 price target on shares of Oxford Nanopore Technologies in a research report on Monday, July 13th. Deutsche Bank Aktiengesellschaft restated a "buy" rating and issued a GBX 195 price target on shares of Oxford Nanopore Technologies in a report on Thursday, August 20th. Citigroup downgraded shares of Oxford Nanopore Technologies to a "buy" rating in a research report on Monday, July 20th. Berenberg Bank dropped their price objective on shares of Oxford Nanopore Technologies from GBX 220 to GBX 200 and set a "buy" rating on the stock in a research note on Wednesday, August 19th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Oxford Nanopore Technologies from GBX 190 to GBX 220 and gave the company an "overweight" rating in a research note on Thursday, August 27th.

Get Our Latest Report on ONT

Insiders Place Their Bets

In other news, insider Adrian Nevil Hennah purchased 24,000 shares of the stock in a transaction that occurred on Monday, October 12th. The stock was acquired at an average cost of GBX 216 per share, with a total value of £51,840. Also, insider Nick Keher purchased 15,325 shares of the company's stock in a transaction that occurred on Friday, September 4th. The shares were purchased at an average cost of GBX 162 per share, for a total transaction of £24,826.50. Over the last ninety days, insiders have purchased 39,885 shares of company stock valued at $7,756,678. Company insiders own 2.53% of the company's stock.

Oxford Nanopore Technologies Trading Up 1.0%

Shares of ONT opened at GBX 211.80 on Friday. The stock's 50-day moving average is GBX 173.15 and its two-hundred day moving average is GBX 138.09. The stock has a market cap of £2.07 billion, a PE ratio of -16.94 and a beta of 0.87. Oxford Nanopore Technologies has a 12 month low of GBX 95.61 and a 12 month high of GBX 238.80. The company has a debt-to-equity ratio of 9.86, a current ratio of 3.52 and a quick ratio of 6.01.

Oxford Nanopore Technologies (LON:ONT - Get Free Report) last issued its earnings results on Wednesday, August 19th. The company reported GBX (4.90) earnings per share for the quarter. Oxford Nanopore Technologies had a negative return on equity of 35.45% and a negative net margin of 54.66%.

About Oxford Nanopore Technologies

(Get Free Report)

Oxford Nanopore Technologies' goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.

Featured Articles

Analyst Recommendations for Oxford Nanopore Technologies (LON:ONT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Oxford Nanopore Technologies Right Now?

Before you consider Oxford Nanopore Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Nanopore Technologies wasn't on the list.

While Oxford Nanopore Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines